Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Best

Showing results (1071-1080 of 1,265) with videos related to

Pageof 127
Sort By:
AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.
Clinical Pharmacokinetics|September 22, 2023
Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed InfantsCindy H T Yeung, Kerri A Bertrand, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2015
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Brookie M Best, Jiajia Wang, et al.
Patient Education and Counseling|February 5, 2022
The impact of COVID-19 on cancer patients, their carers and oncology health professionals: A qualitative studyP Butow, P E Havard, Z Butt, et al.
Journal of Dentistry|May 24, 2025
Clinical performance of at-home dental bleaching in younger and older adults: A non-randomized, double-blind trialHeloisa Forville, Pamela Louise Rodrigues de Andrade, Amanda Gaio Machado, et al.
Journal of Clinical Pharmacology|September 7, 2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and AcyclovirXiaomei I Liu, Jeremiah D Momper, Natella Rakhmanina, et al.
Molecular Biotechnology|February 9, 2005
Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applicationsG Steven Bova, Isam A Eltoum, John A Kiernan, et al.
AIDS (London, England)|February 14, 2006
Impact of pregnancy on abacavir pharmacokineticsBrookie M Best, Mark Mirochnick, Edmund V Capparelli, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
Cell Host & Microbe|May 24, 2016
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon SignalingAlesha Grant, Sanket S Ponia, Shashank Tripathi, et al.
Pageof 127

Showing results (1071-1080 of 1,265) with videos related to

Sort By:
Pageof 127
AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.
Clinical Pharmacokinetics|September 22, 2023
Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed InfantsCindy H T Yeung, Kerri A Bertrand, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2015
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Brookie M Best, Jiajia Wang, et al.
Patient Education and Counseling|February 5, 2022
The impact of COVID-19 on cancer patients, their carers and oncology health professionals: A qualitative studyP Butow, P E Havard, Z Butt, et al.
Journal of Dentistry|May 24, 2025
Clinical performance of at-home dental bleaching in younger and older adults: A non-randomized, double-blind trialHeloisa Forville, Pamela Louise Rodrigues de Andrade, Amanda Gaio Machado, et al.
Journal of Clinical Pharmacology|September 7, 2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and AcyclovirXiaomei I Liu, Jeremiah D Momper, Natella Rakhmanina, et al.
Molecular Biotechnology|February 9, 2005
Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applicationsG Steven Bova, Isam A Eltoum, John A Kiernan, et al.
AIDS (London, England)|February 14, 2006
Impact of pregnancy on abacavir pharmacokineticsBrookie M Best, Mark Mirochnick, Edmund V Capparelli, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
Cell Host & Microbe|May 24, 2016
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon SignalingAlesha Grant, Sanket S Ponia, Shashank Tripathi, et al.
Pageof 127